Telemedicine, diabetes and endocrinologic diseases in the COVID-19 era: the patients’ point of view from a high impacted area. (Preprint)

Carmine Iadarola(University Hospital Foundation), Antonio Di Sabatino(University of Pavia), Sara Cutti(University Hospital Foundation), Giovanni Santacroce(Università Cattolica del Sacro Cuore), Elisa Sprio(University of Pavia), Pietro Carlo Lucotti(University Hospital Foundation), Elisabetta Lovati(University Hospital Foundation)
JMIR Diabetes
May 28, 2020
10.2196/20787
Cited by 0

Related Papers

Decline with age of the respiratory chain activity in human skeletal muscle
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|1994|340
Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol
|Nutrition|2020|264
Anemia in patients with Covid-19: pathogenesis and clinical significance
|Clinical and Experimental Medicine|2021|154
Role of mucosal immunity and epithelial–vascular barrier in modulating gut homeostasis
|Internal and Emergency Medicine|2023|98
Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia
|Gut|2024|96